LOS ANGELES, May 16, 2016 /PRNewswire/ --
TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR ACQUIRED PROVECTUS BIOPHARMACEUTICALS, INC. COMMON STOCK BETWEEN DECEMBER 17, 2013 AND MAY 22, 2014, INCLUSIVE.
YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the Eastern District of Tennessee, that a hearing will be held on September 26, 2016, at 10:00 a.m., before The Honorable Pamela L. Reeves, at the Howard H. Baker, Jr. United States Courthouse, 800 Market Street, Courtroom 3C, Knoxville, Tennessee 37902, for the purpose of determining: (1) whether the proposed Settlement of the claims in the Litigation for the sum of $3.5 million in cash should be approved by the Court as fair, reasonable, and adequate to Members of the Settlement Class; (2) whether to certify the Settlement Class; (3) whether, thereafter, this Litigation should be dismissed with prejudice pursuant to the terms and conditions set forth in the Stipulation of Settlement dated March 8, 2016; (4) whether the proposed plan to distribute the settlement proceeds (the "Plan of Allocation") is fair, reasonable, and adequate and therefore should be approved; (5) whether the application of Plaintiff's Lead Counsel for the payment of attorneys' fees and expenses incurred in connection with this Litigation should be approved; and (6) whether the Court should grant Lead Plaintiff reimbursement of his reasonable costs and expenses (including lost wages) directly related to his representation of the Class.
If you purchased or acquired Provectus Biopharmaceuticals, Inc. common stock between December 17, 2013, and May 22, 2014, inclusive, your rights may be affected by this Settlement. If you have not received a Postcard Notice of the Settlement, you may obtain a copy by contacting Provectus Biopharmaceuticals, Inc. Securities Litigation, c/o KCC Class Action Services, P.O. Box 43408, Providence, RI 02940-3408, 1-844-239-4898, or you can download a copy of the Settlement documents, including the Notice of Proposed Settlement of Class Action, Motion for Attorneys' Fees and Settlement Hearing (the "Internet Long Form Notice"), and the Proof of Claim and Release form at www.provectussecuritieslitigation.com. If you are a Settlement Class Member, in order to share in the distribution of the Net Settlement Fund, you must submit a Proof of Claim and Release form by mail or online such that it is postmarked no later than September 2, 2016, establishing that you are entitled to recovery.
PLEASE DO NOT CONTACT THE COURT OR THE CLERK'S OFFICE REGARDING THIS NOTICE. If you have any questions about the Settlement, you may contact Plaintiff's Lead Counsel at the address listed below:
Kara M. Wolke
Glancy Prongay & Murray LLP
1925 Century Park East, Suite 2100
Los Angeles, California 90067
or go to the following website: www.provectussecuritieslitigation.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/glancy-prongay--murray-llp-announce-settlement-with-provectus-biopharmaceuticals-inc-300262245.html
SOURCE Glancy Prongay & Murray LLP